Macerich CO Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Macerich Co. common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 10.2% of Macerich Co.'s common stock as of April 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 9.3% of Macerich Co.'s common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 13,593,968 shares, representing 5.29% of Macerich Co.'s common stock, as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 9.99% in Macerich Co. (MAC) as of March 31, 2026, holding over 25.6 million shares.
NYSE
Smead Capital Management, Inc., along with William W. Smead and Cole W. Smead, has filed a Schedule 13G, reporting beneficial ownership of 12,155,332.57 shares of Macerich Co. common stock, representing 4.74% of the class.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 4.1% beneficial ownership stake in The Macerich Company's common stock.
NYSE
JPMorgan Chase & Co. has reported a 5.2% beneficial ownership stake in The Macerich Company, totaling 13,381,853 shares of common stock.
NYSE
Smead Capital Management, along with William W. Smead and Cole W. Smead, reported a beneficial ownership of 5.45% in Macerich Co. common stock as of December 31, 2025.
NYSE
FMR LLC and Abigail P. Johnson have disclosed an 8.3% beneficial ownership stake in Macerich Co. common stock as of September 30, 2025.
NYSE
Smead Capital Management, along with William W. Smead and Cole W. Smead, has reported a beneficial ownership of 7.21% in The Macerich Company's common stock as of March 31, 2025.
NYSE
FMR LLC and Abigail P. Johnson have jointly reported a 10.1% beneficial ownership stake in Macerich Co., held for investment purposes in the ordinary course of business.
NYSE
FMR LLC and its affiliates, along with Abigail P. Johnson, have filed an amended Schedule 13G disclosing a beneficial ownership of 9.7% in Macerich Co.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 17.5% of Macerich Co's common stock as of December 31, 2024.